#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

The Empirical Power of Rare Variant Association Methods: Results from Sanger Sequencing in 1,998 Individuals


The role of rare genetic variation in the etiology of complex disease remains unclear. However, the development of next-generation sequencing technologies offers the experimental opportunity to address this question. Several novel statistical methodologies have been recently proposed to assess the contribution of rare variation to complex disease etiology. Nevertheless, no empirical estimates comparing their relative power are available. We therefore assessed the parameters that influence their statistical power in 1,998 individuals Sanger-sequenced at seven genes by modeling different distributions of effect, proportions of causal variants, and direction of the associations (deleterious, protective, or both) in simulated continuous trait and case/control phenotypes. Our results demonstrate that the power of recently proposed statistical methods depend strongly on the underlying hypotheses concerning the relationship of phenotypes with each of these three factors. No method demonstrates consistently acceptable power despite this large sample size, and the performance of each method depends upon the underlying assumption of the relationship between rare variants and complex traits. Sensitivity analyses are therefore recommended to compare the stability of the results arising from different methods, and promising results should be replicated using the same method in an independent sample. These findings provide guidance in the analysis and interpretation of the role of rare base-pair variation in the etiology of complex traits and diseases.


Vyšlo v časopise: The Empirical Power of Rare Variant Association Methods: Results from Sanger Sequencing in 1,998 Individuals. PLoS Genet 8(2): e32767. doi:10.1371/journal.pgen.1002496
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002496

Souhrn

The role of rare genetic variation in the etiology of complex disease remains unclear. However, the development of next-generation sequencing technologies offers the experimental opportunity to address this question. Several novel statistical methodologies have been recently proposed to assess the contribution of rare variation to complex disease etiology. Nevertheless, no empirical estimates comparing their relative power are available. We therefore assessed the parameters that influence their statistical power in 1,998 individuals Sanger-sequenced at seven genes by modeling different distributions of effect, proportions of causal variants, and direction of the associations (deleterious, protective, or both) in simulated continuous trait and case/control phenotypes. Our results demonstrate that the power of recently proposed statistical methods depend strongly on the underlying hypotheses concerning the relationship of phenotypes with each of these three factors. No method demonstrates consistently acceptable power despite this large sample size, and the performance of each method depends upon the underlying assumption of the relationship between rare variants and complex traits. Sensitivity analyses are therefore recommended to compare the stability of the results arising from different methods, and promising results should be replicated using the same method in an independent sample. These findings provide guidance in the analysis and interpretation of the role of rare base-pair variation in the etiology of complex traits and diseases.


Zdroje

1. LiuDJLealSM 2010 Replication strategies for rare variant complex trait association studies via next-generation sequencing. Am J Hum Genet 87 790 801

2. LiuDJLealSM 2010 A novel adaptive method for the analysis of next-generation sequencing data to detect complex trait associations with rare variants due to gene main effects and interactions. PLoS Genet 6 e1001156 doi:10.1371/journal.pgen.1001156

3. CohenJCKissRSPertsemlidisAMarcelYLMcPhersonR 2004 Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305 869 872

4. Ionita-LazaIBuxbaumJDLairdNMLangeC 2011 A new testing strategy to identify rare variants with either risk or protective effect on disease. PLoS Genet 7 e1001289 doi:10.1371/journal.pgen.1001289

5. BodmerWBonillaC 2008 Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 40 695 701

6. EmisonESGarcia-BarceloMGriceEALantieriFAmielJ 2010 Differential contributions of rare and common, coding and noncoding Ret mutations to multifactorial Hirschsprung disease liability. Am J Hum Genet 87 60 74

7. StrangerBEStahlEARajT 2011 Progress and promise of genome-wide association studies for human complex trait genetics. Genetics 187 367 383

8. FraylingIMBeckNEIlyasMDove-EdwinIGoodmanP 1998 The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. Proceedings of the National Academy of Sciences of the United States of America 95 10722 10727

9. LakenSJPetersenGMGruberSBOddouxCOstrerH 1997 Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nature genetics 17 79 83

10. AsimitJZegginiE 2010 Rare variant association analysis methods for complex traits. Annu Rev Genet 44 293 308

11. PriceALKryukovGVde BakkerPIPurcellSMStaplesJ 2010 Pooled association tests for rare variants in exon-resequencing studies. Am J Hum Genet 86 832 838

12. LiBLealSM 2009 Discovery of rare variants via sequencing: implications for the design of complex trait association studies. PLoS Genet 5 e1000481 doi:10.1371/journal.pgen.1000481

13. LiQZhangHYuK 2010 Approaches for evaluating rare polymorphisms in genetic association studies. Hum Hered 69 219 228

14. HanFPanW 2010 A data-adaptive sum test for disease association with multiple common or rare variants. Hum Hered 70 42 54

15. ZhuXFengTLiYLuQElstonRC 2010 Detecting rare variants for complex traits using family and unrelated data. Genet Epidemiol 34 171 187

16. MorrisAPZegginiE 2010 An evaluation of statistical approaches to rare variant analysis in genetic association studies. Genet Epidemiol 34 188 193

17. MadsenBEBrowningSR 2009 A groupwise association test for rare mutations using a weighted sum statistic. PLoS Genet 5 e1000384 doi:10.1371/journal.pgen.1000384

18. LiYByrnesAELiM 2010 To identify associations with rare variants, just WHaIT: Weighted haplotype and imputation-based tests. Am J Hum Genet 87 728 735

19. WangTLinCYRohanTEYeK 2010 Resequencing of pooled DNA for detecting disease associations with rare variants. Genet Epidemiol 34 492 501

20. LiBLealSM 2008 Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. Am J Hum Genet 83 311 321

21. NejentsevSWalkerNRichesDEgholmMToddJA 2009 Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324 387 389

22. FlanaganSEPatchAMEllardS 2010 Using SIFT and PolyPhen to predict loss-of-function and gain-of-function mutations. Genet Test Mol Biomarkers 14 533 537

23. NealeBMRivasMAVoightBFAltshulerDDevlinB 2011 Testing for an unusual distribution of rare variants. PLoS Genet 7 e1001322 doi:10.1371/journal.pgen.1001322

24. WuMCLeeSCaiTLiYBoehnkeM 2011 Rare-variant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet 89 82 93

25. WaplesRSFaulknerJR 2009 Modelling evolutionary processes in small populations: not as ideal as you think. Mol Ecol 18 1834 1847

26. MukhopadhyayIFeingoldEWeeksDEThalamuthuA 2010 Association tests using kernel-based measures of multi-locus genotype similarity between individuals. Genet Epidemiol 34 213 221

27. PriceALKryukovGVde BakkerPIPurcellSMStaplesJ 2010 Pooled association tests for rare variants in exon-resequencing studies. American journal of human genetics 86 832 838

28. Keen-KimDMathewsCAReusVILoweTLHerreraLD 2006 Overrepresentation of rare variants in a specific ethnic group may confuse interpretation of association analyses. Hum Mol Genet 15 3324 3328

29. FirmannMMayorVVidalPMBochudMPecoudA 2008 The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC cardiovascular disorders 8 6

30. SongKNMAponteJManasESBacanuS-AYuanXCardonLMooserVEWhittakerJCWaterworthD 2011 Sequencing of Lp-PLA2-encoding PLA2G7 gene in 2000 Europeans reveals several rare loss-of-function mutations Pharmacogenomics

31. VoelkerdingKVDamesSADurtschiJD 2009 Next-generation sequencing: from basic research to diagnostics. Clin Chem 55 641 658

32. ShendureJJiH 2008 Next-generation DNA sequencing. Nat Biotechnol 26 1135 1145

33. RichardsJBRivadeneiraFInouyeMPastinenTMSoranzoN 2008 Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet 371 1505 1512

34. RichardsJBWaterworthDO'RahillySHivertMFLoosRJ 2009 A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet 5 e1000768 doi:10.1371/journal.pgen.1000768

35. Lango AllenHEstradaKLettreGBerndtSIWeedonMN 2010 Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467 832 838

36. HegeleRA 2009 Plasma lipoproteins: genetic influences and clinical implications. Nat Rev Genet 10 109 121

37. Frikke-SchmidtRNordestgaardBGJensenGBTybjaerg-HansenA 2004 Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J Clin Invest 114 1343 1353

Štítky
Genetika Reprodukčná medicína

Článok vyšiel v časopise

PLOS Genetics


2012 Číslo 2
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#